Bioworks Corporation announced that it has received equity round of funding on January 15, 2024. The transaction included the participation from new investors Purpose Venture Capital, Lavender Hill Capital Partners, 18 Salisbury Capital Limited, Yagi & Co.,Ltd and and other international investors. The company will issue the shares through third-party allotment method.

The company has raised ¥2.5 billion in funding till the date.